PL2352497T3 - Proces przygotowania estrów aminokwasowych delta-9-thc - Google Patents
Proces przygotowania estrów aminokwasowych delta-9-thcInfo
- Publication number
- PL2352497T3 PL2352497T3 PL09824226T PL09824226T PL2352497T3 PL 2352497 T3 PL2352497 T3 PL 2352497T3 PL 09824226 T PL09824226 T PL 09824226T PL 09824226 T PL09824226 T PL 09824226T PL 2352497 T3 PL2352497 T3 PL 2352497T3
- Authority
- PL
- Poland
- Prior art keywords
- thc
- delta
- preparation
- amino acid
- acid esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B13/00—Accessories or details of general applicability for machines or apparatus for cleaning
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B3/00—Cleaning by methods involving the use or presence of liquid or steam
- B08B3/02—Cleaning by the force of jets or sprays
- B08B3/026—Cleaning by making use of hand-held spray guns; Fluid preparations therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B2203/00—Details of cleaning machines or methods involving the use or presence of liquid or steam
- B08B2203/02—Details of machines or methods for cleaning by the force of jets or sprays
- B08B2203/0264—Splash guards
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Addiction (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11016508P | 2008-10-31 | 2008-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2352497T3 true PL2352497T3 (pl) | 2017-08-31 |
Family
ID=42129588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09824226T PL2352497T3 (pl) | 2008-10-31 | 2009-11-02 | Proces przygotowania estrów aminokwasowych delta-9-thc |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8809261B2 (pl) |
| EP (1) | EP2352497B1 (pl) |
| JP (1) | JP5739344B2 (pl) |
| AU (1) | AU2009308665B2 (pl) |
| CA (1) | CA2741862C (pl) |
| DK (1) | DK2352497T3 (pl) |
| ES (1) | ES2622582T3 (pl) |
| HK (1) | HK1158517A1 (pl) |
| HU (1) | HUE032158T2 (pl) |
| PL (1) | PL2352497T3 (pl) |
| WO (1) | WO2010051541A2 (pl) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160345631A1 (en) | 2005-07-19 | 2016-12-01 | James Monsees | Portable devices for generating an inhalable vapor |
| US8991402B2 (en) | 2007-12-18 | 2015-03-31 | Pax Labs, Inc. | Aerosol devices and methods for inhaling a substance and uses thereof |
| ES2622582T3 (es) * | 2008-10-31 | 2017-07-06 | University Of Mississippi | Proceso para la preparación de ésteres de delta-9-THC-aminoácido |
| WO2011113855A2 (en) | 2010-03-17 | 2011-09-22 | Novaliq Gmbh | Pharmaceutical composition for treatment of increased intraocular pressure |
| US10517530B2 (en) | 2012-08-28 | 2019-12-31 | Juul Labs, Inc. | Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances |
| CN113952321B (zh) | 2012-09-12 | 2023-03-28 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| AU2013314303B2 (en) | 2012-09-12 | 2018-01-18 | Novaliq Gmbh | Semifluorinated alkane compositions |
| US10279934B2 (en) | 2013-03-15 | 2019-05-07 | Juul Labs, Inc. | Fillable vaporizer cartridge and method of filling |
| CA3143647C (en) | 2013-05-06 | 2023-09-19 | Juul Labs, Inc. | Nicotine salt formulations for aerosol devices and methods thereof |
| CN111642812A (zh) | 2013-06-14 | 2020-09-11 | 尤尔实验室有限公司 | 电子汽化设备中的具有单独的可汽化材料的多个加热元件 |
| IL308151B2 (en) | 2013-12-05 | 2024-12-01 | Juul Labs Inc | Nicotine liquid formulations for aerosol devices and methods thereof |
| DE202014011313U1 (de) | 2013-12-23 | 2019-03-29 | Juul Labs Uk Holdco Limited | Systeme für eine Verdampfungsvorrichtung |
| US10159282B2 (en) | 2013-12-23 | 2018-12-25 | Juul Labs, Inc. | Cartridge for use with a vaporizer device |
| USD825102S1 (en) | 2016-07-28 | 2018-08-07 | Juul Labs, Inc. | Vaporizer device with cartridge |
| USD842536S1 (en) | 2016-07-28 | 2019-03-05 | Juul Labs, Inc. | Vaporizer cartridge |
| US10058129B2 (en) | 2013-12-23 | 2018-08-28 | Juul Labs, Inc. | Vaporization device systems and methods |
| US20160366947A1 (en) | 2013-12-23 | 2016-12-22 | James Monsees | Vaporizer apparatus |
| US10076139B2 (en) | 2013-12-23 | 2018-09-18 | Juul Labs, Inc. | Vaporizer apparatus |
| CA2948851A1 (en) | 2014-05-16 | 2015-11-19 | Pax Labs, Inc. | Systems and methods for aerosolizing a smokeable material |
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| CA3111682A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| EP4464356A3 (en) | 2014-12-05 | 2025-01-08 | Juul Labs, Inc. | Calibrated dose control |
| WO2016147186A1 (en) * | 2015-03-19 | 2016-09-22 | One World Cannabis Ltd | Preparations of cannabis emulsions and methods thereof |
| CN105037180B (zh) * | 2015-04-19 | 2017-10-10 | 安徽省逸欣铭医药科技有限公司 | 一种双重作用的中枢性镇痛新化合物、制备方法及用途 |
| EP3297617A4 (en) * | 2015-05-18 | 2019-02-20 | 5071, Inc. | HOMOGENEOUS CANNABIS COMPOSITIONS AND METHODS OF PRODUCING THE SAME |
| WO2016186735A1 (en) | 2015-05-18 | 2016-11-24 | 5071, Inc. | Homogenous cannabis compositions and methods of making the same |
| GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| EP3495023B1 (en) | 2015-09-30 | 2020-04-22 | Novaliq GmbH | Semifluorinated compounds and their compositions |
| AU2016329261B2 (en) | 2015-09-30 | 2020-05-07 | Novaliq Gmbh | Semifluorinated compounds for ophthalmic administration |
| JP6676176B2 (ja) | 2016-01-29 | 2020-04-08 | ユニヴァーシティー オブ ミシシッピ | 生物学的に活性なカンナビジオール類似体 |
| MX2018009703A (es) | 2016-02-11 | 2019-07-08 | Juul Labs Inc | Cartuchos de fijacion segura para dispositivos vaporizadores. |
| SG11201806793TA (en) | 2016-02-11 | 2018-09-27 | Juul Labs Inc | Fillable vaporizer cartridge and method of filling |
| US10405582B2 (en) | 2016-03-10 | 2019-09-10 | Pax Labs, Inc. | Vaporization device with lip sensing |
| WO2017180953A1 (en) * | 2016-04-15 | 2017-10-19 | Ronald Silver | Cannabis infused sweeteners and elixirs |
| US20220087972A9 (en) | 2016-04-15 | 2022-03-24 | Sre Wellness, Inc. | Cannabinoid Compositions |
| EP3442522A4 (en) * | 2016-04-15 | 2020-01-01 | SRE Wellness, Inc. | PROCESS FOR PRODUCING HYDROPHILIZED CANNABIS OIL USING EMULSIFIERS, AND COMPOSITIONS OF CANNABINOIDS THEREOF |
| USD849996S1 (en) | 2016-06-16 | 2019-05-28 | Pax Labs, Inc. | Vaporizer cartridge |
| US20170362195A1 (en) * | 2016-06-16 | 2017-12-21 | Full Spectrum Laboratories Ltd | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use |
| USD851830S1 (en) | 2016-06-23 | 2019-06-18 | Pax Labs, Inc. | Combined vaporizer tamp and pick tool |
| USD848057S1 (en) | 2016-06-23 | 2019-05-07 | Pax Labs, Inc. | Lid for a vaporizer |
| USD836541S1 (en) | 2016-06-23 | 2018-12-25 | Pax Labs, Inc. | Charging device |
| US11660403B2 (en) | 2016-09-22 | 2023-05-30 | Juul Labs, Inc. | Leak-resistant vaporizer device |
| CN109906085B (zh) | 2016-09-23 | 2024-03-08 | 诺瓦利克有限责任公司 | 含有环孢素的眼用组合物 |
| BR112019006194A2 (pt) | 2016-09-28 | 2019-06-18 | Novaliq Gmbh | composições que compreendem um ligante de ligação ao receptor de canabinóides |
| US11117852B2 (en) | 2017-04-05 | 2021-09-14 | University Of Mississippi | Isolation of pure cannabinoids from Cannabis |
| ES2957559T3 (es) | 2017-04-21 | 2024-01-22 | Dermaliq Therapeutics Inc | Composiciones de yodo |
| WO2018206656A1 (en) | 2017-05-12 | 2018-11-15 | Novaliq Gmbh | Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions |
| EP3424493A1 (en) * | 2017-07-07 | 2019-01-09 | SolMic Research GmbH | Stable cannabinoid compositions |
| EP3424494A1 (en) * | 2017-07-07 | 2019-01-09 | SolMic Research GmbH | Stable cannabinoid compositions |
| CA3069694A1 (en) * | 2017-07-14 | 2019-01-17 | 5071, Inc. | Cannabinoid compositions and methods of preparation thereof |
| KR102652605B1 (ko) * | 2017-08-27 | 2024-03-28 | 로드스 테크놀로지즈 | 안과 질환 치료를 위한 약학제적 조성물 |
| USD887632S1 (en) | 2017-09-14 | 2020-06-16 | Pax Labs, Inc. | Vaporizer cartridge |
| JP2020535156A (ja) | 2017-09-27 | 2020-12-03 | ノバリック ゲーエムベーハー | 眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物 |
| WO2019068763A1 (en) | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | OPHTHALMIC COMPOSITIONS COMPRISING F6H8 |
| CA3083622A1 (en) * | 2017-11-27 | 2019-05-31 | Beleave Inc. | Extraction and purification of cannabinoid compounds |
| GB201806953D0 (en) | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
| CN112153970A (zh) | 2018-04-27 | 2020-12-29 | 诺瓦利克有限责任公司 | 用于治疗青光眼的包含他氟前列素的眼用组合物 |
| WO2020074697A1 (en) | 2018-10-12 | 2020-04-16 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| CA3118895A1 (en) * | 2018-11-07 | 2020-05-14 | Columbia Care Llc | Suppository formulations having cannabinoid |
| WO2020167751A1 (en) * | 2019-02-11 | 2020-08-20 | Chancey John | Methods of making and using phytocannabinoids complexed with a protein, peptide, amino acid, polysaccharide, disaccharide, ormonosaccharide |
| WO2020186077A1 (en) * | 2019-03-12 | 2020-09-17 | 6th Wave Innovations Corp. | Molecularly imprinted polymers for extraction of cannabinoids and uses thereof |
| EP3952860A1 (en) * | 2019-04-09 | 2022-02-16 | Powderpost LLC | Methods and compositions for use in treatment of cancer without psychoactive effects |
| GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| CA3181092A1 (en) | 2020-06-30 | 2022-01-06 | Nathan Bryson | Tryptamine prodrugs |
| US11242328B1 (en) | 2021-02-25 | 2022-02-08 | Acid Neutral Alkaline Laboratory | Heterogeneous catalyst and method for preparation of aromatic tricyclic pyrans |
| US11242330B1 (en) | 2021-02-25 | 2022-02-08 | Acid Neutral Alkaline Laboratory | Organic catalyst and method for preparation of aromatic tricyclic pyrans |
| US11352337B1 (en) * | 2021-06-02 | 2022-06-07 | Acid Neutral Alkaline Laboratory | Zeolite catalyst and method for preparation of aromatic tricyclic pyrans |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB313977A (en) * | 1927-12-21 | 1929-06-21 | British United Shoe Machinery | Improvements in or relating to boot or shoe sewing machines or methods of making boots or shoes by the use thereof |
| JPS5518709B2 (pl) | 1970-02-13 | 1980-05-21 | ||
| US4933363A (en) * | 1988-08-16 | 1990-06-12 | Elsohly Mahmoud A | Method for effecting systemic delivery of delta-9-tetrahydrocannabinol |
| US6040298A (en) * | 1992-12-23 | 2000-03-21 | Oclassen Pharmaceuticals, Inc. | Methods for treatment with compositions effective against acyclovir-resistant strains of herpes viruses |
| US5389375A (en) * | 1993-05-21 | 1995-02-14 | University Of Mississippi | Stable suppository formulations effecting bioavailability of Δ9 -thc |
| US5631297A (en) * | 1994-07-11 | 1997-05-20 | Pate; David W. | Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same |
| US6008383A (en) * | 1998-10-26 | 1999-12-28 | University Of Mississippi | Method of preparing delta-9-tetrahydrocannabinol esters |
| US20060078955A1 (en) | 2004-10-13 | 2006-04-13 | Lin-Zhi International | Method for retrieving delta9-THC from oral fluid |
| JP2008522959A (ja) | 2004-11-02 | 2008-07-03 | シャイア エルエルシー | 肝臓への送達を改善したリバビリンのプロドラッグ |
| EP2046290A4 (en) * | 2006-08-04 | 2011-08-17 | Insys Therapeutics Inc | AQUEOUS DRONABINOL FORMULATIONS |
| WO2008134668A2 (en) * | 2007-04-27 | 2008-11-06 | Alexza Pharmaceuticals, Inc. | Heat-labile prodrugs |
| WO2009026461A2 (en) * | 2007-08-21 | 2009-02-26 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
| US20100303883A1 (en) * | 2007-10-17 | 2010-12-02 | Axxia Pharmaceuticals, Llc | Polymeric drug delivery systems and thermoplastic extrusion processes for producing such systems |
| PL2963031T3 (pl) | 2007-11-30 | 2019-08-30 | Zynerba Pharmaceuticals, Inc. | Proleki tetrahydrokannabinolu, kompozycje zawierające proleki tetrahydrokannabinolu i sposoby ich stosowania |
| US20090169629A1 (en) * | 2008-01-02 | 2009-07-02 | Novagali Pharma Sa | Micellar compositions with ophthalmic applications |
| EP2151234A1 (en) * | 2008-07-28 | 2010-02-10 | Laboratorios Del. Dr. Esteve, S.A. | Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion |
| ES2622582T3 (es) * | 2008-10-31 | 2017-07-06 | University Of Mississippi | Proceso para la preparación de ésteres de delta-9-THC-aminoácido |
-
2009
- 2009-11-02 ES ES09824226.6T patent/ES2622582T3/es active Active
- 2009-11-02 JP JP2011534860A patent/JP5739344B2/ja active Active
- 2009-11-02 AU AU2009308665A patent/AU2009308665B2/en active Active
- 2009-11-02 US US13/126,606 patent/US8809261B2/en active Active
- 2009-11-02 DK DK09824226.6T patent/DK2352497T3/en active
- 2009-11-02 PL PL09824226T patent/PL2352497T3/pl unknown
- 2009-11-02 CA CA2741862A patent/CA2741862C/en active Active
- 2009-11-02 WO PCT/US2009/062998 patent/WO2010051541A2/en active Application Filing
- 2009-11-02 HU HUE09824226A patent/HUE032158T2/en unknown
- 2009-11-02 EP EP09824226.6A patent/EP2352497B1/en active Active
-
2011
- 2011-11-30 HK HK11113006.2A patent/HK1158517A1/zh unknown
-
2014
- 2014-08-18 US US14/462,482 patent/US9630941B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20150045282A1 (en) | 2015-02-12 |
| DK2352497T3 (en) | 2017-04-03 |
| US20110275555A1 (en) | 2011-11-10 |
| CA2741862C (en) | 2017-10-17 |
| AU2009308665A1 (en) | 2010-05-06 |
| EP2352497A4 (en) | 2012-08-01 |
| HUE032158T2 (en) | 2017-09-28 |
| EP2352497B1 (en) | 2017-02-22 |
| CA2741862A1 (en) | 2010-05-06 |
| US8809261B2 (en) | 2014-08-19 |
| US9630941B2 (en) | 2017-04-25 |
| EP2352497A2 (en) | 2011-08-10 |
| WO2010051541A3 (en) | 2010-07-08 |
| HK1158517A1 (zh) | 2012-07-20 |
| ES2622582T3 (es) | 2017-07-06 |
| AU2009308665B2 (en) | 2015-10-22 |
| JP5739344B2 (ja) | 2015-06-24 |
| JP2012507568A (ja) | 2012-03-29 |
| WO2010051541A2 (en) | 2010-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2352497T3 (pl) | Proces przygotowania estrów aminokwasowych delta-9-thc | |
| EP2248906A4 (en) | PROCESS FOR THE PREPARATION OF L-AMINO ACID | |
| EP2425007A4 (en) | PREPARATION OF FATTY ACID ESTERS | |
| ZA201005436B (en) | Process for preparation of high purity methacrylic acid | |
| EP2444389A4 (en) | PROCESS FOR THE PREPARATION OF 2-FLUOROACRYLIC ESTERS | |
| PH12012500561A1 (en) | Production of fatty acid derivatives | |
| EP2417246A4 (en) | PRODUCTION OF FATTY ACID DERIVATIVES | |
| IL206664A0 (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
| HK1172625A1 (en) | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester (r)-1--2-- | |
| ZA201203615B (en) | Derivatives of 1-amino-2-cyclobutylethylboronic acid | |
| ZA201109362B (en) | Method for preparation of carbamic acid (r)-1-aryl-2-tetrazolyl-ethyl ester | |
| PL2387558T3 (pl) | Sposób wytwarzania i rozdzielania kwasu 2-acyloamino-3-difenylopropanowego | |
| ZA201100528B (en) | Method for the synthesis of bioresourced acrylic acid esters | |
| EP2290092A4 (en) | PROCESS FOR PRODUCTION OF L-AMINO ACID | |
| ZA201200160B (en) | Process for preparation of (fluoroalkylthio)acetic acid esters | |
| IL220211A0 (en) | Process for the preparation of 1-alkyl-/1-aryl-5-pyrazolecarboxylic acid derivatives | |
| PL2240477T3 (pl) | Nowy sposób wytwarzania estrów skopiny | |
| EP2471943A4 (en) | PROCESS FOR THE PREPARATION OF L-AMINO ACID | |
| EP2471942A4 (en) | PROCESS FOR THE PREPARATION OF L-AMINO ACID | |
| PL2358851T5 (pl) | Zastosowanie kwasu metanosulfonowego do wytwarzania estrów kwasów tłuszczowych | |
| IL219832A0 (en) | Process for preparation of (z)-cyanoalkenylcyclopropanecarboxylic acid compounds | |
| IL215870A0 (en) | Processes for purification of 1-methylpyrzole-4-carboxylic acid esters | |
| EP2154232A4 (en) | PROCESS FOR THE PRODUCTION OF FATTY ACID ESTERS | |
| IL201584A0 (en) | Process for the preparation of pure acrylate esters | |
| EP2452945A4 (en) | PHOSPHONIC POLYFLUOROALKYL ACID ESTER AND PROCESS FOR PRODUCTION THEREOF |